(Q38440701)

3 September 2017

title

JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance (English)

1 reference

3 September 2017

Martha Wadleigh

0 references

Ayalew Tefferi

object named as

Ayalew Tefferi

1 reference

3 September 2017

Susan M Schwager

1 reference

3 September 2017

Stephanie J Lee

1 reference

3 September 2017

author name string

Alexandra P Wolanskyj

1 reference

3 September 2017

Terra L Lasho

1 reference

3 September 2017

Rebecca F McClure

1 reference

3 September 2017

D Gary Gilliland

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

British Journal of Haematology

3 September 2017

published in

1 reference

3 September 2017

volume

131

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

208-213

1 reference

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Essential thrombocythaemia: challenges and evidence-based management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

Identification of an acquired JAK2 mutation in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05764.X

10.1111/J.1365-2141.2005.05764.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference